Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on September 2, 2026

Sep. 2, 2026

vTv Therapeutics to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Amlogenyx to Present at the Wells Fargo 21ˢᵗ Annual Healthcare Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

Disc Medicine to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Annexon to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Geron to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

U.S Court of Appeals Officially Vacates Injunction Previously Restraining Genius Group’s Business Operations

Indeterminate GlobeNewswire

Sep. 2, 2026

3 E Network Enters into $1M Private Placement to CEO-Led Entity at $1.426 Per Share

Indeterminate GlobeNewswire

Sep. 2, 2026

Pakistan Arrives at LEAP 2026 with Largest-Ever Delegation, Backing “Think Tech, Think Pakistan” with Scale

Indeterminate GlobeNewswire

Sep. 2, 2026

Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study

Indeterminate GlobeNewswire

Sep. 2, 2026

Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform

Indeterminate GlobeNewswire

Sep. 2, 2026

Rezolute to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Dyne Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

Indeterminate GlobeNewswire

Sep. 2, 2026

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

Indeterminate GlobeNewswire

Sep. 2, 2026

Charles IT Expands AI and Automation Capabilities Through Acquisition of Descent

Indeterminate GlobeNewswire

Sep. 2, 2026

Cardiff Oncology to Participate in September 2026 Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Aeluma to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 16, 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire